Improving Health Through Clinical Research

Who We Are

Qualmedica Research is a multi-site clinical research company offering clinical trials in Indiana and Kentucky, USA.

We have provided high quality, compliant research since 1996.  Our goal is to deliver exceptional service to drug sponsors, collaborative project support to physicians and CROs, and empathetic care to our patient volunteers.

Our mission is to enable better health for patients that will benefit from new or improved drugs.  We partner with physicians and sponsors to bring therapeutics to market that are safe, effective, and meaningful to a patient’s quality of life.  We are dedicated to improving health through research.

Qualmedica Research has experience conducting phase II, III, and IV clinical trials across a comprehensive list of conditions.  Our customer list includes more than 100 pharmaceutical companies and CROs.

Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 24,000 global professionals works in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere. Our depth of industry knowledge and strong track record gained over the past 40 years is moving the industry forward and advancing clinical research in healthcare’s most complex areas, while our innovation ecosystem offers the best quality solutions to make every phase of the clinical trial process more efficient. With the people, insight and focus on operational excellence, we work With Heart™ every day to treat patients with dignity and continuously learn from their experiences, so every trial makes a difference. This approach continues to earn us recognition industrywide, with Parexel being named “Best Contract Research Organization” in November 2023 by an independent panel for Citeline, “Top CRO to Work With” by investigative sites worldwide in the 2023 WCG CenterWatch Global Site Relationship Benchmark Survey and recipient of the 2023 Society for Clinical Research Sites (SCRS) Eagle Award for advancing the clinical research profession through strong site partnerships. For more information, visit www.parexel.com.

Phase II, III, and IV clinical trials including the following services:

Clinical Operations

Regulatory interaction and documentation

Study oversight and coordination

Subject recruitment

Subject enrollment and informed consent

Subject randomization and dosing

Medical care

Electronic Data Capture

Reporting and documentation (case report forms)

Join our mailing list

Have news about upcoming studies delivered right to your inbox.

Pin It on Pinterest